For Immediate Release

Cibus Leadership to Present at High-Profile Industry Conferences in the Coming Year

San Diego (April 18, 2017) — Cibus, a biotechnology company committed to bringing progress to farm, food and industry, will discuss its product pipeline and the future of food at several upcoming biotechnology conferences. Executives will participate in discussions about the latest tools revolutionizing plant breeding.

“Cibus is leading the way in the effort to produce natural, healthy and sustainable solutions for farmers and consumers,” said Peter Beetham, PhD, President & Chief Executive Officer, Cibus. “We look forward to sharing how a range of products in our commercial pipeline will contribute to a brighter future for our planet by focusing on disease resistance, methods of combating environmental stress, healthier oils and other strategies for improving productivity.”

Cibus executives will be participating at the following events:

CRISPR AgBio (San Diego, California, April 18-19, 2017): Cibus is a program sponsor at the inaugural meeting dedicated to helping agricultural biotech and agrochemical companies leverage the power of CRISPR and advanced trait breeding technology to overcome productivity challenges, increase yield and pioneer Sustainable Agriculture in plant breeding. Greg Gocal, Chief Scientific Officer, will present “Precision Gene Editing in Agriculture” on Tuesday, April 18.

Broad Institute’s Genome Engineering 5.0 (Cambridge, Massachusetts, May 7-9, 2017): Each year, this peer-to-peer workshop highlights some of the most exciting recent advances in genome engineering technology and application. Dr. Gocal will speak at the biotechnology session on Tuesday, May 9 to discuss oligo directed mutagenesis and how Cibus is accelerating plant breeding.

4th Annual CRISPR Precision Gene Editing Congress (Boston, Massachusetts, February 26-28, 2018): Cibus will sponsor the Congress in Boston, which will unite large pharma, biotech, leading academia and technology providers. Attendees and presenters will discuss how to optimize the adoption of CRISPR gene editing in human health and plant breeding programs.

For more information or to schedule an interview with a Cibus representative, please contact Shawna McGregor at 917-971-7852 or .

About Cibus

Cibus (www.cibus.com) Cibus is an innovative plant breeding company offering its first commercialized product, SU Canola™, as well as a pipeline of crops featuring beneficial traits scheduled for commercialization over the next decade. Cibus crops offer benefits for the consumer, farmer and food industry including healthier oil profiles, disease resistance and drought tolerance. Cibus’ non-transgenic technology provides it access to global multibillion-dollar markets in agriculture, specialty chemicals, and human health. Cibus has a worldwide presence, with subsidiaries in both Europe and North America, including Nucelis, its bio-industrials division, and a state-of-the-art research and development center in San Diego, California. Cibus’ core purpose is to lead the transition to sustainable non-transgenic agricultural and industrial products and improved human health by harvesting nature’s diversity. For more information, visit cibus.com. Find Cibus on LinkedIn, Twitter, Instagram and Google+.